Among adult gliomas, IDH-mutant astrocytoma is second only to IDH wild-type glioblastoma in incidence, with an average survival time of 7–8 years, better than IDH wild-type glioblastoma and worse than oligodendroglioma [2–8]. The gene discussed is IDH1; the disease is central nervous system cancer.